Methylphenidate/naltrexone(Avekshan)

N/A

Report date: 2022/03/07 17:31:58

Base Information

Drug NameMethylphenidate/naltrexone(Avekshan)
Drug Alias NameAVK-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine oxidase inhibitorsPolyamine uptake inhibitorsMu opioid receptor antagonists +[5] 
TargetsAdrenergic receptorsMonoamine oxidaseMu opioid receptor
Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvekshan Llc
China Registration ClassN/A

Develop Information

Active CompaniesAvekshan Llc
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with Hyperactivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A